Mayo Clinic Upper Digestive Disease Survey
Launched by MAYO CLINIC · Aug 20, 2015
Trial Information
Current as of May 12, 2025
Recruiting
Keywords
ClinConnect Summary
The Mayo Clinic Upper Digestive Disease Survey is a clinical trial designed to help improve the care of patients with esophageal conditions, including esophageal cancer. This study is focused on creating a set of questionnaires that will help doctors consistently evaluate how well patients are doing after procedures like esophagectomy, which is surgery to remove part of the esophagus. By collecting and analyzing the responses from these questionnaires, researchers aim to establish what is considered a "normal" recovery for different types of treatments, which will assist in managing symptoms and complications, as well as educating patients before surgery.
To participate in this trial, individuals must be undergoing or have already undergone esophagectomy or esophageal reconstruction. The study is open to all genders and is particularly looking for participants aged 65 to 74. If you join, you'll complete questionnaires about your health and recovery, which will contribute to better treatment plans and support for people facing similar health challenges. Your input will be valuable in helping doctors understand how to improve care for patients with upper digestive diseases.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing or having already undergone an esophagectomy or esophageal reconstruction.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Luis Tapias Vargas, MD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials